Cite
APA Citation
Campbell, C., Mercuri, E., Baranello, G., Kirschner, J., Servais, L., Goemans, N., Pera, M., Buchbjerg, J., Yeung, W., Kletzl, H., Gerber, M., Czech, C., Cleary, Y., Gorni, K., & Khwaja, O. (n.d.). p.063 SUNFISH Part 1 results and Part 2 trial design in patients with type 2/3 spinal muscular atrophy (SMA) receiving risdiplam (RG7916). Canadian journal of neurological sciences, 46, S31. http://access.bl.uk/ark:/81055/vdc_100101980602.0x00002c